MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

Search

Select Medical Holdings Corp

Atvērts

SektorsVeselības aprūpe

15.24 2.08

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

14.86

Max

15.26

Galvenie mērījumi

By Trading Economics

Ienākumi

-14M

44M

Pārdošana

24M

1.4B

P/E

Sektora vidējais

18.476

90.831

Dividenžu ienesīgums

2.46

Peļņas marža

3.24

Darbinieki

30,000

EBITDA

-15M

120M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+25.75% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.46%

2.20%

Nākamie ieņēmumi

2026. g. 19. febr.

Nākamais dividenžu datums

2026. g. 12. marts

Nākamais Ex dividenžu datums

2026. g. 2. marts

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

107M

1.9B

Iepriekšējā atvēršanas cena

13.16

Iepriekšējā slēgšanas cena

15.24

Ziņu noskaņojums

By Acuity

26%

74%

43 / 361 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Select Medical Holdings Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. janv. 22:41 UTC

Iegādes, apvienošanās, pārņemšana

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

2026. g. 15. janv. 00:00 UTC

Peļņas

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

2026. g. 14. janv. 23:47 UTC

Tirgus saruna

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

2026. g. 14. janv. 23:44 UTC

Tirgus saruna

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

2026. g. 14. janv. 23:39 UTC

Tirgus saruna

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

2026. g. 14. janv. 23:32 UTC

Tirgus saruna

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026. g. 14. janv. 22:56 UTC

Iegādes, apvienošanās, pārņemšana

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

2026. g. 14. janv. 22:53 UTC

Iegādes, apvienošanās, pārņemšana

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

2026. g. 14. janv. 22:17 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 14. janv. 22:17 UTC

Tirgus saruna

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

2026. g. 14. janv. 22:09 UTC

Peļņas

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

2026. g. 14. janv. 22:08 UTC

Peļņas

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

2026. g. 14. janv. 22:08 UTC

Peļņas

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

2026. g. 14. janv. 21:53 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

2026. g. 14. janv. 21:53 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

2026. g. 14. janv. 21:52 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Announces Positive Profit Alert for 2025

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Citigroup Acting as Financial Advisor to WuXi XDC

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: Aims to Keep Listing Status of BioDlink

2026. g. 14. janv. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

2026. g. 14. janv. 21:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2026. g. 14. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 14. janv. 21:49 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC: BioDlink Offer to Cost HK$2.79B

2026. g. 14. janv. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

2026. g. 14. janv. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

WuXi XDC Makes Cash Offer for BioDlink International

2026. g. 14. janv. 21:13 UTC

Tirgus saruna

Oil Retreats Late After Trump Comments on Iran -- Market Talk

2026. g. 14. janv. 20:30 UTC

Tirgus saruna
Peļņas

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

2026. g. 14. janv. 20:13 UTC

Tirgus saruna

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

2026. g. 14. janv. 20:08 UTC

Tirgus saruna

Oil Futures Extend Rally on Iran Tensions -- Market Talk

2026. g. 14. janv. 19:33 UTC

Tirgus saruna

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

2026. g. 14. janv. 19:06 UTC

Tirgus saruna
Peļņas

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Salīdzinājums

Cenas izmaiņa

Select Medical Holdings Corp Prognoze

Cenas mērķis

By TipRanks

25.75% augšup

Prognoze 12 mēnešiem

Vidējais 18.75 USD  25.75%

Augstākais 21 USD

Zemākais 17 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Select Medical Holdings Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

4

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

14.67 / 15.14Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

43 / 361 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Select Medical Holdings Corp

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
help-icon Live chat